Adamis pharmaceuticals announces closing of public offering of common stock

San diego, feb. 02, 2021 (globe newswire) -- adamis pharmaceuticals corporation (nasdaq: admp), today announced the closing of its underwritten public offering of 46,621,621 shares of its common stock, including 6,081,081 shares sold pursuant to the exercise in full of the underwriters' option to purchase additional shares, at the public offering price of $1.11 per share. as a result of the underwriters' exercise of the option, the aggregate gross proceeds to adamis from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by the company, was approximately $51.7 million.
ADMP Ratings Summary
ADMP Quant Ranking